WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized as a 2025 Industry and Regional ...

WuXi Biologics ranks in the top 1% of companies assessed in the pharmaceutical industry. In recent years, WuXi Biologics' ESG strategy and initiatives have made significant progress and gained ...

For a small island of just over 5 million people on Europe's western edge, Ireland is playing an outsize role in the travel ...

Asian equities ended the week mixed, led higher by Hong Kong, especially Hong Kong-listed growth stocks, while Taiwan underperformed.

If Trump’s talks with Putin facilitate a pause in the fighting, Ukraine will decline in salience as a point of contention ...

Find insights on China’s healthcare sector, Thomson Medical Group, Cochlear, and more in the latest Market Talks covering the ...

President Donald Trump plans to nominate Landon Heid, who served on the staff of the House of Representatives' Select ...

Heid, a China hawk who helped set technology policy for the congressional committee, is being tapped to be assistant ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

The Hong Kong stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it ...